MX2020004693A - Proceso para preparar partículas de isoxazolina de gran tamaño. - Google Patents

Proceso para preparar partículas de isoxazolina de gran tamaño.

Info

Publication number
MX2020004693A
MX2020004693A MX2020004693A MX2020004693A MX2020004693A MX 2020004693 A MX2020004693 A MX 2020004693A MX 2020004693 A MX2020004693 A MX 2020004693A MX 2020004693 A MX2020004693 A MX 2020004693A MX 2020004693 A MX2020004693 A MX 2020004693A
Authority
MX
Mexico
Prior art keywords
large size
preparing large
isoxazoline
particles
isoxazoline particles
Prior art date
Application number
MX2020004693A
Other languages
English (en)
Inventor
Zhou George X
Aaron Cote
Luke Ryan Schenck
Athanas Koynov
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of MX2020004693A publication Critical patent/MX2020004693A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/04—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/80—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Abstract

La solicitud se refiere a un proceso para producir partículas grandes del compuesto isoxazolina que comprende iniciar la cristalización y después mantener la temperatura de la cristalización en la región metaestable eliminando, recalentando y reciclando una porción del solvente permitiendo así que los cristales existentes crezcan más grandes mientras se minimiza la formación de nuevos cristales más pequeños.
MX2020004693A 2017-11-07 2018-11-06 Proceso para preparar partículas de isoxazolina de gran tamaño. MX2020004693A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762582381P 2017-11-07 2017-11-07
US201762608904P 2017-12-21 2017-12-21
PCT/EP2018/080230 WO2019091940A1 (en) 2017-11-07 2018-11-06 Process for preparing large size isoxazoline particles

Publications (1)

Publication Number Publication Date
MX2020004693A true MX2020004693A (es) 2020-08-20

Family

ID=64172503

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020004693A MX2020004693A (es) 2017-11-07 2018-11-06 Proceso para preparar partículas de isoxazolina de gran tamaño.

Country Status (16)

Country Link
US (1) US11858904B2 (es)
EP (1) EP3707129A1 (es)
JP (3) JP7446222B2 (es)
KR (1) KR20200085295A (es)
CN (1) CN111295375A (es)
AU (2) AU2018363686B2 (es)
BR (1) BR112020008848A2 (es)
CA (1) CA3081653A1 (es)
CL (1) CL2020001172A1 (es)
CO (1) CO2020006258A2 (es)
IL (1) IL274075A (es)
MX (1) MX2020004693A (es)
PE (1) PE20210170A1 (es)
PH (1) PH12020500586A1 (es)
UA (1) UA127892C2 (es)
WO (1) WO2019091940A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210177808A1 (en) 2017-11-07 2021-06-17 Intervet Inc. Injectable isoxazoline pharmaceutical compositions and their use against parasite infestation
AU2021277491A1 (en) 2020-05-20 2022-12-01 Intervet International B.V. Injectable pharmaceutical compositions and uses thereof
CN112724095A (zh) * 2020-09-25 2021-04-30 安徽省公众检验研究院有限公司 氟雷拉钠晶型及其制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102558082B (zh) 2004-03-05 2015-09-30 日产化学工业株式会社 异噁唑啉取代苯甲酰胺化合物的制备中间体
TWI412322B (zh) 2005-12-30 2013-10-21 Du Pont 控制無脊椎害蟲之異唑啉
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
BRPI0810929B8 (pt) 2007-06-27 2022-12-06 Du Pont uso de um composto de fórmula 1
TWI556741B (zh) 2007-08-17 2016-11-11 英特威特國際股份有限公司 異唑啉組成物及其作為抗寄生蟲藥上的應用
JP5365807B2 (ja) 2007-11-12 2013-12-11 日産化学工業株式会社 光学活性イソキサゾリン化合物の触媒的不斉合成方法
TWI411395B (zh) 2007-12-24 2013-10-11 Syngenta Participations Ag 殺蟲化合物
US8389738B2 (en) * 2008-07-09 2013-03-05 Nissan Chemical Industries, Ltd. Production method of isoxazoline-substituted benzoic acid amide compound
EP2379544B1 (en) 2008-12-18 2013-10-16 Novartis AG Isoxazolines derivatives and their use as pesticide
AU2009327079B2 (en) 2008-12-19 2013-02-14 Elanco Tiergesundheit Ag Isoxazoline derivatives and their use as pesticide
CN102596172A (zh) * 2009-06-24 2012-07-18 Msd欧斯股份有限公司 含有阿塞那平的注射剂和使用其的治疗方法
JP5679102B2 (ja) 2009-08-03 2015-03-04 日産化学工業株式会社 ジヒドロイソキサゾール置換安息香酸化合物の光学活性体とジアステレオマー塩及びその製造方法
TWI487486B (zh) 2009-12-01 2015-06-11 Syngenta Participations Ag 以異唑啉衍生物為主之殺蟲化合物
DE102010003711B4 (de) * 2010-04-08 2015-04-09 Jesalis Pharma Gmbh Verfahren zur Herstellung kristalliner Wirkstoffpartikel
KR20130124458A (ko) 2010-05-27 2013-11-14 이 아이 듀폰 디 네모아 앤드 캄파니 4-[5-[3-클로로-5-(트라이플루오로메틸)페닐]-4,5-다이하이드로-5-(트라이플루오로메틸)-3-아이속사졸릴]-n-[2-옥소-2-[(2,2,2-트라이플루오로에틸)아미노]에틸]-1-나프탈렌카르복스아미드의 결정 형태
AU2013245478A1 (en) 2012-11-01 2014-05-15 Sumitomo Chemical Company, Limited Method for administering agent for controlling ectoparasite to dog
CN105121416B (zh) 2013-02-14 2018-12-04 日产化学工业株式会社 异噁唑啉取代苯甲酰胺化合物的结晶性多晶型物及其制造方法
JP2015028006A (ja) 2013-06-27 2015-02-12 日産化学工業株式会社 イソキサゾリン化合物の結晶性多形体およびその製造方法
US10350196B2 (en) 2013-09-30 2019-07-16 Zoetis Services Llc Long-acting spiro-isoxazoline formulations
JP6581586B2 (ja) * 2013-12-20 2019-09-25 インターベット インターナショナル ベー． フェー． イソオキサゾリン組成物および動物における寄生虫侵襲の予防または処置におけるその使用
UY36570A (es) 2015-02-26 2016-10-31 Merial Inc Formulaciones inyectables de acción prolongada que comprenden un agente activo isoxazolina, métodos y usos de las mismas
EA202090762A1 (ru) 2015-04-08 2020-09-08 Мериал, Инк. Инъецируемые препараты замедленного высвобождения, содержащие изоксазолиновое действующее вещество, способы и применение
UY37137A (es) 2016-02-24 2017-09-29 Merial Inc Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos
US20210177808A1 (en) 2017-11-07 2021-06-17 Intervet Inc. Injectable isoxazoline pharmaceutical compositions and their use against parasite infestation

Also Published As

Publication number Publication date
CN111295375A (zh) 2020-06-16
IL274075A (en) 2020-06-30
CO2020006258A2 (es) 2020-05-29
RU2020117583A3 (es) 2021-12-24
RU2020117583A (ru) 2021-12-08
EP3707129A1 (en) 2020-09-16
US20200331867A1 (en) 2020-10-22
AU2024201160A1 (en) 2024-03-14
PH12020500586A1 (en) 2021-06-21
JP2024010042A (ja) 2024-01-23
JP7446222B2 (ja) 2024-03-08
PE20210170A1 (es) 2021-01-29
UA127892C2 (uk) 2024-02-07
CL2020001172A1 (es) 2020-10-23
BR112020008848A2 (pt) 2020-10-20
JP2021501755A (ja) 2021-01-21
AU2018363686B2 (en) 2023-11-23
KR20200085295A (ko) 2020-07-14
WO2019091940A1 (en) 2019-05-16
JP2023099059A (ja) 2023-07-11
CA3081653A1 (en) 2019-05-16
US11858904B2 (en) 2024-01-02
AU2018363686A1 (en) 2020-05-07

Similar Documents

Publication Publication Date Title
CO2020006258A2 (es) Proceso para preparar partículas de isoxazolina de gran tamaño
AR101079A1 (es) Producción de hidróxido de litio
CL2017000819A1 (es) Métodos para separar diastereoisoméros de fosfato
AR107649A1 (es) Método para producir d-psicosa de alta pureza
AR098942A1 (es) Procedimiento de preparación de un material adsorbente conformado en ausencia de aglutinante, y procedimiento de extracción de litio a partir de soluciones salinas que utilizan dicho material
CO6541539A2 (es) Procesos para preparar las formas cristalinas a y b de ilaprazol y proceso para convertir las formas cristalinas
MX2017014958A (es) Metodo de produccion de forma cristalina de enzalutamida.
MY174160A (en) Polyvinylidene fluoride resin particles and method for producing same
NZ751256A (en) Method for producing the crystalline form of modification a of calcobutrol
AR104902A1 (es) Procedimiento de preparación de un material absorbente que comprende una etapa de precipitación de boehmita
RU2017102893A (ru) Способ отделения тритиевой воды от легкой воды
NZ724923A (en) Crystalline forms of grapiprant
AR081267A1 (es) Procedimiento de obtencion de la forma cristalina a del febuxostat
MY173758A (en) Method for producing ddr-type zeolite crystals and method for producing ddr-type zeolite membrane
EA201490708A1 (ru) Способ получения синтетической пены с регулируемым распределением частиц
BR112018005934A2 (pt) formas cristalinas de intermediário de posaconazol e processo para a preparação de posaconazol amorfo
BR112015023343A2 (pt) método para preparar sovaprevir, método de preparar um composto da fórmula (c), método de preparação do composto f-2, composto, processo, método de preparação de uma forma amorfa pura de sovaprevir, e,forma cristalina de sovaprevir
AR099070A1 (es) Ácido (s)- 3-metil-abscísico y ésteres del mismo
AR104145A1 (es) Método de producción de epirrubicina, intermediario y sal farmacéutica
BR112017003715A2 (pt) método para sintetizar peneiras moleculares de silicoaluminofosfato-34 usando monoisopropanol amina
AR071804A1 (es) Cristales de sucralosa enjuagados con regulador (buffer)
RU2014150353A (ru) Способ выращивания монокристалла метафторидобората бария-натрия Ba2Na3(B3O6)2F
IN2013MU03508A (es)
EA201790917A1 (ru) Способ получения углеродного материала высокой плотности для углеродных электродов высокой плотности
AR118693A1 (es) Métodos para producir l-glufosinato de amonio monohidrato cristalino